Century Therapeutics, Inc. Common Stock
IPSC
IPSC: Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.
moreShow IPSC Financials
Recent trades of IPSC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by IPSC's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Artificial cell death polypeptide for chimeric antigen receptor and uses thereof May. 30, 2023
Federal grants, loans, and purchases
Followers on IPSC's company Twitter account
Number of mentions of IPSC in WallStreetBets Daily Discussion
Recent insights relating to IPSC
Recent picks made for IPSC stock on CNBC
ETFs with the largest estimated holdings in IPSC
Flights by private jets registered to IPSC